Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Completed
CT.gov ID
NCT04753242
Collaborator
(none)
230
22
9.8
10.5
1.1

Study Details

Study Description

Brief Summary

Heads of all psychosomatic, psychiatric and psychological consultation and liaison (C&L) services in acute care hospitals across all participating countries will be contacted and asked to participate in this international cross-sectional online survey. The survey consists of questions about care structures and their utilisation that psychosomatic, psychiatric and psychological C&L services have established in acute hospitals in the context of the COVID 19 pandemic.

Condition or Disease Intervention/Treatment Phase
  • Other: Online survey questionnaire

Detailed Description

Background:

The COVID-19 pandemic raised new challenges in supporting patients, relatives and staff for psychosomatic, psychiatric and psychological C&L services in general hospitals worldwide. It is intended to build upon the experience gained so far in order to be well prepared for the future.

Objectives:

The aims of this international online survey are

  1. To summarize the efforts made in psychosocial care in the context of the COVID-19 pandemic.

  2. To assess the experiences made with the established services so far.

  3. To assess the need for networking, cooperation and support.

  4. Improvement of psychosocial care in acute hospitals in the context of pandemics.

Study Design:

This health services research project will be carried out as an observational study in the form of an international cross-sectional online survey.

There will be one survey time point. Study reporting will follow the STROBE Statement (Strengthening the Reporting of Observational Studies in Epidemiology).

Ethic approval:

In all participating countries the respective ethics committees were informed about the survey and it was checked with them, how far and what kind of country-specific vote of an ethics committee was necessary. Written statements, declarations or votes were obtained from all participating countries.

Setting:

The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries are contacted and asked to participate. Contact is made via the respective national professional societies and relevant working and interest groups.

Participants This study is an international online survey with psychosomatic, psychiatric and psychological C&L services from 14 European countries (Austria, Belgium, Finland, Germany, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Switzerland, United Kingdom) as well as parts of Canada (Quebec and Ontario region) and Iran participating.

Country specific regions:

The national coordinators of the participating country provided lists of specific regions for their respective country following the NUTS logic (Nomenclature of Territorial Units for Statistics; https://en.wikipedia.org/wiki/Nomenclature_of_Territorial_Units_for_Statistics), preferably a NUTS level that leads to 5 - 20 NUTS for each country.

Online survey questionnaire:

Self-developed questionnaire based on relevant literature, own experience and consultation with participating professional societies. The survey contains 25 questions on structural and process variables regarding characterization of the participating C&L services, involvement of the respective hospitals in the physical care of COVID-19 patients, structures / organization of psychosocial care for COVID-19 patients in the participating hospitals, specific psychosocial support for patients, relatives and staff established in the participating hospital in the context of COVID-19, communication - How the different target groups were informed about the COVID-19 related psychosocial support services and offers, burden of the COVID-19 pandemic on the psychosocial C&L teams, needs and wishes for the future.

The study questionnaire was translated by a professional company from German into English, French and Italian. Language harmonization and cultural adaptation followed a modified committee-based approach informed by the European Social Survey (ESS) Round 9 Translation Guidelines. Participants are free to choose the language version to be worked on.

Study Design

Study Type:
Observational
Actual Enrollment :
230 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals - an International Online Survey of Psychosomatic, Psychiatric and Psychological Consultation and Liaison (C&L) Services
Actual Study Start Date :
Dec 8, 2020
Actual Primary Completion Date :
Oct 3, 2021
Actual Study Completion Date :
Oct 3, 2021

Outcome Measures

Primary Outcome Measures

  1. Structural and process quality of COVID-19 related psychosocial C&L services [6 months]

    Data basis for improving quality of COVID-19 related psychosocial C&L services: characterization of participating C&L services involvement of respective hospitals in the physical care of COVID-19 patients structures/ organization of psychosocial care for COVID-19 patients in participating hospitals specific psychosocial support established in participating hospitals in context of COVID-19 for patients relatives staff communication strategies - How the different target groups were informed about COVID-19 related psychosocial support services and offers burden of COVID-19 pandemic on psychosocial C&L teams needs and wishes of the participating psychosocial C&L services for support or exchange of experience regarding psychosocial care in the COVID 19 context for changes / improvements considered essential for the future with regard to psychosocial care services in the participating hospitals in the COVID-19 context

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries
Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Graz, University Hospital Graz Graz Steiermark Austria 8036
2 Ghent University Hospital, Department of Psychiatry Ghent Belgium
3 University of Montreal, Department of Psychosomatic Medicine Montreal Canada
4 TorontoSinai Health, University of Toronto, Department of Psychiatry Toronto Canada
5 Oulu University Hospital and University of Oulu Oulu Finland 90220
6 Université de Paris, Service de Psychiatrie de l'adulte Paris France
7 Nuremberg Hospital, Department of Psychosomatic Medicine and Psychotherapy Nürnberg Bayern Germany 90419
8 University Hospital Cologne, Department of Psychosomatics and Psychotherapy Köln Nordrhein-Westfalen Germany 50937
9 Aristotle University Thessaloniki Thessaloniki Greece
10 University of Medical Sciences, Department of Psychiatry Tehran Iran, Islamic Republic of
11 University College Dublin Dublin Ireland
12 Bologna University Bologna Italy 40123
13 University of Modena & Reggio Emilia Modena Italy 411274
14 Oslo University Hospital Oslo Norway
15 Wroclaw Medical University Wroclaw Poland
16 Hospital de Santa Maria Lisboa Portugal
17 Universidade Católica Portuguesa Lisboa Lisboa Portugal
18 Barcelona University Barcelona Spain
19 University Hospital Basel, Department of Psychosomatic Medicine Basel Basel-City Switzerland 4031
20 University of Basel, Department of Psychiatry (UPK) Basel Switzerland 4002
21 University of Exeter Exeter United Kingdom
22 University of York York United Kingdom

Sponsors and Collaborators

  • University Hospital, Basel, Switzerland

Investigators

  • Principal Investigator: Rainer Schaefert, Prof. Dr. med., University Hospital, Basel, Switzerland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT04753242
Other Study ID Numbers:
  • Req-2020-00861; th21Schaefert
First Posted:
Feb 15, 2021
Last Update Posted:
Oct 28, 2021
Last Verified:
Oct 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Basel, Switzerland
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 28, 2021